US Stock MarketDetailed Quotes

Cardio Diagnostics (CDIO)

Watchlist
  • 2.010
  • +0.050+2.55%
Close Apr 17 16:00 ET
  • 1.970
  • -0.040-1.99%
Post 20:01 ET
5.95MMarket Cap-0.54P/E (TTM)

Cardio Diagnostics (CDIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-57.51%14.83K
-21.21%3.56K
-56.61%2.86K
-5.02%7.48K
-94.10%940
104.45%34.89K
-15.03%4.51K
-34.40%6.58K
356.23%7.87K
15.93K
Operating revenue
-57.51%14.83K
-21.21%3.56K
-56.61%2.86K
-5.02%7.48K
-94.10%940
104.45%34.89K
-15.03%4.51K
-34.40%6.58K
356.23%7.87K
--15.93K
Cost of revenue
Gross profit
Operating expense
-22.64%6.5M
-3.56%1.47M
21.12%1.71M
30.68%1.69M
-60.91%1.63M
15.72%8.4M
-1.71%1.52M
-2.66%1.42M
-49.50%1.29M
145.08%4.17M
Selling and administrative expenses
-28.95%5.79M
-10.43%1.17M
8.13%1.52M
30.68%1.69M
-61.91%1.58M
14.91%8.15M
-14.60%1.31M
-0.37%1.41M
-49.15%1.29M
158.01%4.16M
-Selling and marketing expense
-37.75%766.89K
-70.46%321.32K
270.16%192.7K
----
21.56%41.82K
677.20%1.23M
2,412.77%1.09M
52.81%52.06K
82.80%57.78K
-30.57%34.4K
-General and administrative expense
-27.39%5.03M
282.08%852.93K
-1.95%1.33M
----
-62.61%1.54M
-0.22%6.92M
-85.03%223.24K
-1.69%1.35M
-51.30%1.22M
164.00%4.12M
Research and development costs
181.28%641.21K
40.21%286.87K
3,502.99%189.05K
----
-79.70%2.2K
57.02%227.97K
2,630.90%204.6K
-86.44%5.25K
-40.89%7.28K
-87.49%10.84K
Depreciation amortization depletion
230.49%65.23K
5.72%5.66K
17.76%5.66K
----
848.01%45.44K
2.90%19.74K
11.39%5.35K
0.00%4.8K
0.02%4.79K
0.17%4.79K
-Depreciation and amortization
230.49%65.23K
5.72%5.66K
17.76%5.66K
----
848.01%45.44K
2.90%19.74K
11.39%5.35K
0.00%4.8K
0.02%4.79K
0.17%4.79K
Operating profit
22.49%-6.48M
3.51%-1.46M
-21.48%-1.71M
-30.90%-1.68M
60.79%-1.63M
-15.51%-8.37M
1.66%-1.52M
2.44%-1.41M
49.77%-1.28M
-144.14%-4.16M
Net non-operating interest income expense
19.84%-14.09K
26.15%-2.15K
18.34%-2.94K
18.70%-4.5K
18.64%-4.5K
99.74%-17.58K
96.97%-2.91K
99.37%-3.6K
99.47%-5.54K
99.89%-5.54K
Non-operating interest income
-33.08%712
-33.94%146
-32.50%189
-32.62%190
-33.45%187
-0.37%1.06K
-26.58%221
-1.06%280
7.22%282
27.15%281
Non-operating interest expense
-20.60%14.8K
-26.70%2.29K
-19.36%3.13K
-19.37%4.69K
-19.36%4.69K
-99.72%18.64K
-96.75%3.13K
-99.32%3.88K
-99.45%5.82K
-99.88%5.82K
Other net income (expense)
Special income (charges)
----
----
----
----
----
--0
--0
--0
--0
----
Income before tax
22.49%-6.5M
3.55%-1.47M
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
22.49%-6.5M
3.55%-1.47M
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
Net income continuous Operations
22.49%-6.5M
3.55%-1.47M
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
Minority interest income
Net income attributable to the parent company
22.49%-6.5M
3.55%-1.47M
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.49%-6.5M
3.55%-1.47M
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
Basic earnings per share
60.32%-3.71
-185.71%-0.8
43.35%-0.98
43.27%-0.97
83.64%-0.97
52.78%-9.35
-0.28
63.96%-1.73
85.38%-1.71
-79.70%-5.93
Diluted earnings per share
60.32%-3.71
-185.71%-0.8
43.35%-0.98
43.27%-0.97
83.64%-0.97
52.78%-9.35
-0.28
63.96%-1.73
85.38%-1.71
-79.70%-5.93
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -57.51%14.83K-21.21%3.56K-56.61%2.86K-5.02%7.48K-94.10%940104.45%34.89K-15.03%4.51K-34.40%6.58K356.23%7.87K15.93K
Operating revenue -57.51%14.83K-21.21%3.56K-56.61%2.86K-5.02%7.48K-94.10%940104.45%34.89K-15.03%4.51K-34.40%6.58K356.23%7.87K--15.93K
Cost of revenue
Gross profit
Operating expense -22.64%6.5M-3.56%1.47M21.12%1.71M30.68%1.69M-60.91%1.63M15.72%8.4M-1.71%1.52M-2.66%1.42M-49.50%1.29M145.08%4.17M
Selling and administrative expenses -28.95%5.79M-10.43%1.17M8.13%1.52M30.68%1.69M-61.91%1.58M14.91%8.15M-14.60%1.31M-0.37%1.41M-49.15%1.29M158.01%4.16M
-Selling and marketing expense -37.75%766.89K-70.46%321.32K270.16%192.7K----21.56%41.82K677.20%1.23M2,412.77%1.09M52.81%52.06K82.80%57.78K-30.57%34.4K
-General and administrative expense -27.39%5.03M282.08%852.93K-1.95%1.33M-----62.61%1.54M-0.22%6.92M-85.03%223.24K-1.69%1.35M-51.30%1.22M164.00%4.12M
Research and development costs 181.28%641.21K40.21%286.87K3,502.99%189.05K-----79.70%2.2K57.02%227.97K2,630.90%204.6K-86.44%5.25K-40.89%7.28K-87.49%10.84K
Depreciation amortization depletion 230.49%65.23K5.72%5.66K17.76%5.66K----848.01%45.44K2.90%19.74K11.39%5.35K0.00%4.8K0.02%4.79K0.17%4.79K
-Depreciation and amortization 230.49%65.23K5.72%5.66K17.76%5.66K----848.01%45.44K2.90%19.74K11.39%5.35K0.00%4.8K0.02%4.79K0.17%4.79K
Operating profit 22.49%-6.48M3.51%-1.46M-21.48%-1.71M-30.90%-1.68M60.79%-1.63M-15.51%-8.37M1.66%-1.52M2.44%-1.41M49.77%-1.28M-144.14%-4.16M
Net non-operating interest income expense 19.84%-14.09K26.15%-2.15K18.34%-2.94K18.70%-4.5K18.64%-4.5K99.74%-17.58K96.97%-2.91K99.37%-3.6K99.47%-5.54K99.89%-5.54K
Non-operating interest income -33.08%712-33.94%146-32.50%189-32.62%190-33.45%187-0.37%1.06K-26.58%221-1.06%2807.22%28227.15%281
Non-operating interest expense -20.60%14.8K-26.70%2.29K-19.36%3.13K-19.37%4.69K-19.36%4.69K-99.72%18.64K-96.75%3.13K-99.32%3.88K-99.45%5.82K-99.88%5.82K
Other net income (expense)
Special income (charges) ----------------------0--0--0--0----
Income before tax 22.49%-6.5M3.55%-1.47M-21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M
Income tax 0000000000
Net income 22.49%-6.5M3.55%-1.47M-21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M
Net income continuous Operations 22.49%-6.5M3.55%-1.47M-21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M
Minority interest income
Net income attributable to the parent company 22.49%-6.5M3.55%-1.47M-21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.49%-6.5M3.55%-1.47M-21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M
Basic earnings per share 60.32%-3.71-185.71%-0.843.35%-0.9843.27%-0.9783.64%-0.9752.78%-9.35-0.2863.96%-1.7385.38%-1.71-79.70%-5.93
Diluted earnings per share 60.32%-3.71-185.71%-0.843.35%-0.9843.27%-0.9783.64%-0.9752.78%-9.35-0.2863.96%-1.7385.38%-1.71-79.70%-5.93
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More